Your browser doesn't support javascript.
loading
Oral and gut dysbiosis leads to functional alterations in Parkinson's disease.
Jo, Sungyang; Kang, Woorim; Hwang, Yun Su; Lee, Seung Hyun; Park, Kye Won; Kim, Mi Sun; Lee, Hyunna; Yoon, Hyung Jeong; Park, Yoo Kyoung; Chalita, Mauricio; Lee, Je Hee; Sung, Hojun; Lee, Jae-Yun; Bae, Jin-Woo; Chung, Sun Ju.
Affiliation
  • Jo S; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
  • Kang W; Department of Biology and Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, 02447, South Korea.
  • Hwang YS; CJ Bioscience Inc, Seoul, 04527, South Korea.
  • Lee SH; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
  • Park KW; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
  • Kim MS; Department of Neurology, Uijeongbu Eulji Medical Center, Eulji University School of Medicine, Uijeongbu-si, Gyeonggi-do, 11759, South Korea.
  • Lee H; Department of Neurology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, 05505, South Korea.
  • Yoon HJ; Bigdata Research Center, Asan Institute for Life Sciences, Asan Medical Center, Seoul, 05505, South Korea.
  • Park YK; Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Gyeonggi-do, 17104, South Korea.
  • Chalita M; Department of Medical Nutrition, Graduate School of East-West Medical Science, Kyung Hee University, Yongin, Gyeonggi-do, 17104, South Korea.
  • Lee JH; CJ Bioscience Inc, Seoul, 04527, South Korea.
  • Sung H; CJ Bioscience Inc, Seoul, 04527, South Korea.
  • Lee JY; Department of Biology and Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, 02447, South Korea.
  • Bae JW; Department of Biology and Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, 02447, South Korea.
  • Chung SJ; Department of Biology and Department of Life and Nanopharmaceutical Sciences, Kyung Hee University, Seoul, 02447, South Korea.
NPJ Parkinsons Dis ; 8(1): 87, 2022 Jul 07.
Article in En | MEDLINE | ID: mdl-35798742
ABSTRACT
Although several studies have identified a distinct gut microbial composition in Parkinson's disease (PD), few studies have investigated the oral microbiome or functional alteration of the microbiome in PD. We aimed to investigate the connection between the oral and gut microbiome and the functional changes in the PD-specific gut microbiome using shotgun metagenomic sequencing. The taxonomic composition of the oral and gut microbiome was significantly different between PD patients and healthy controls (P = 0.003 and 0.001, respectively). Oral Lactobacillus was more abundant in PD patients and was associated with opportunistic pathogens in the gut (FDR-adjusted P < 0.038). Functional analysis revealed that microbial gene markers for glutamate and arginine biosynthesis were downregulated, while antimicrobial resistance gene markers were upregulated in PD patients than healthy controls (all P < 0.001). We identified a connection between the oral and gut microbiota in PD, which might lead to functional alteration of the microbiome in PD.

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Parkinsons Dis Year: 2022 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: NPJ Parkinsons Dis Year: 2022 Document type: Article